AGP Picks
View all

Get your science and technology news from Africa

Provided by AGP

Sci-Tech Today: Africa: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Today: Africa.

Press releases published on April 14, 2026

New Fellowship Offering Affordable U.S.-Accredited Degrees and Mentorship Launches to Prepare African Youth for Careers
Couplr.ai Partners with InterGen Data to Drive Organic Growth, Advisor Productivity, Client Retention, and Revenue
GoldHaven Announces Change of Auditor
Imperial Reports Mount Polley Production Update for 2026 First Quarter
기업의 약 80%는 “데이터 접근성 문제로 AI 활용에 제약”… Cloudera 보고서
Cloudera 最新报告发现:近 80% 的企业表示 AI 发展受限于数据访问难题
クラウデラの最新レポートによると、企業の80%近くが、AIの導入がデータアクセスの課題によって阻害されていると回答
Hampir 80% Perusahaan Menyatakan AI Terhalang oleh Cabaran Akses Data, Laporan Baharu Cloudera Mendedahkan
Cloudera 最新報告發現,近 80% 企業認為數據存取的困難阻礙了人工智能的發展
Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma
ZenaTech cierra la adquisición de NOW Solutions Inc., amplía su división SaaS empresarial con clientes gubernamentales y del sector público y fortalece el crecimiento de los ingresos recurrentes
Akaysha Energy Begins Construction on Elaine BESS, Supported by InEight Document
Broadcom Announces Extended Partnership with Meta to Deploy Technology to Support Multi-Gigawatts of Meta’s Custom Silicon, MTIA
AI-powered Social News Network Pulse Launches to Deliver High-Signal Insights for Professionals
Stride Announces Date for Third Quarter Fiscal Year 2026 Earnings Call
Dumb Money Announces Public Launch as Retail Investors Reclaim the Market Narrative
Parker to Announce Fiscal 2026 Third Quarter Earnings on April 30; Conference Call and Webcast Scheduled for 11 a.m. Eastern
Mercury Systems to Report Third Quarter Fiscal Year 2026 Financial Results on May 5, 2026
South Africa's Leading Business Plan Consultants Deliver 3,000+ Investor-Ready Plans
Aligos Therapeutics Announces First Interim Analysis Results from the Phase 2 B-SUPREME Study of Pevifoscorvir Sodium in Participants with Chronic Hepatitis B Virus Infection and Grant of FDA Fast Track Designation

Share us

on your social networks:

Sign up for:

Sci-Tech Today: Africa

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.